Navigation Links
Morrison & Foerster's Kate Murashige Wins Chambers Lifetime Achievement Award
Date:6/22/2012

NEW YORK and SAN DIEGO, June 22, 2012 /PRNewswire/ -- At its seventh annual Awards for Excellence dinner June 7, Chambers USA presented its 2012 "Lifetime Achievement Award" to Kate H. Murashige, senior partner in Morrison & Foerster's San Diego office.

Chambers honored Dr. Murashige for her significant and continued accomplishments in patent prosecution work. She was one of only three attorneys recognized individually for Chambers' Special Awards during this year's event, and the only lawyer to win the Lifetime Achievement Award. The other two honorees, who both won awards for "Outstanding Contribution in the Legal Profession," were appellate lawyer Seth P. Waxman from WilmerHale, and plaintiffs' lawyer Elizabeth J. Cabraser from Lieff Cabraser Heimann & Bernstein.

In honoring Dr. Murashige, Chambers noted that she "is the most distinguished name among a host of leading lights at Morrison & Foerster and is regarded as a pioneer for the entire technology industry thanks to her seminal work on patent prosecution for biotech and pharma clients."

Dr. Murashige has led a number of noteworthy matters during the course of her career. She prosecuted a bovine growth hormone patent on behalf of the University of California, which took approximately 20 years from application to its issuance in 2000. On the eve of trial, biotech giant Monsanto settled related infringement claims with the university in 2006. The long-term licensing revenue to the university was valued at potentially more than $250 million.

Dr. Murashige, who holds a Ph.D. in biochemistry from University of California, Los Angeles, has served on the National Institutes of Health as a member of its National Biotechnology Policy Board, and has been a member of the Scientific Freedom and Responsibility Committee of the American Association for the Advancement of Science. She has also taught college chemistry and was the Physical Sciences Chairperson at the College of San Mateo for six years.

Also this year Chambers shortlisted Morrison & Foerster's Corporate/M&A and Bankruptcy practices for Awards for Excellence.

Morrison & Foerster Chair Keith Wetmore stated, "We are delighted to see Chambers recognize Kate's remarkable career as a trailblazer in intellectual property law. Kate's career is rich with milestones in advising many innovative technology companies in building and securing their patent portfolios. It's also gratifying to see both our M&A and bankruptcy groups spotlighted by Chambers for the annual Awards of Excellence, underscoring the firm's eminence and continued success in these practice areas."

ABOUT MOFO.
We are Morrison & Foerster — a global firm of exceptional credentials. Our clients include some of the largest financial institutions, investment banks, Fortune 100, technology and life science companies. We've been included on The American Lawyer's A-List for eight straight years, and Fortune named us one of the "100 Best Companies to Work For." Our lawyers are committed to achieving innovative and business-minded results for our clients, while preserving the differences that make us stronger. This is MoFo.

Contact: Amy Merriweather, Public Relations Manager, Morrison & Foerster 415-268-6063 amerriweather@mofo.com


'/>"/>
SOURCE Morrison & Foerster
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
2. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
3. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
4. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
5. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
8. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
9. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
10. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Gen-Probe Incorporated in Connection with the Sale of the Company to Hologic, Inc.
11. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/11/2017)... Oct. 11, 2017  True Health, a leader ... its effort during National Breast Cancer Awareness month ... risks. Research ... calculated that more than 10 million American women ... in BRCA1 or BRCA2 and have not had testing. ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based ... and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored ... 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, ...
Breaking Medicine News(10 mins):